GLP-1 drugs: what North Dakota Medicaid paid

Q: Does a paid prescription mean North Dakota Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

North Dakota Medicaid shows a published payment figure for 5 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read North Dakota Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What North Dakota Medicaid’s payment record shows

In 2026Q1, the product North Dakota Medicaid paid for most often was Ozempic®, at 1,762 prescriptions¹⁹ of the 2,346 to 2,445^{7,19,25,37,43} across all 8 products, or 75 percent of the published count.

North Dakota Medicaid itself reimbursed at least $2,174,162 for these products in the quarter, about $931 per prescription. Pharmacies were paid $2,191,959 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Mounjaro®, at about $1,083.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what North Dakota Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, North Dakota Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What North Dakota Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what North Dakota Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Not published	Withheld	n/a	Not published	Not published	Not published
tirzepatideMounjaro®	Fee-for-service	at least 44⁷	2%	$47,641	$47,641	$1,083
semaglutideWegovy®	Not published	Withheld	n/a	Not published	Not published	Not published
semaglutideOzempic®	Fee-for-service	1,762¹⁹	75%	$1,752,427	$1,770,225	$995
semaglutideRybelsus®	Fee-for-service	at least 30²⁵	1%	$30,166	$30,166	$1,006
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	487³⁷	21%	$338,771	$338,771	$696
liraglutideliraglutide (generic)	Fee-for-service	at least 12⁴³	<1%	$5,156	$5,156	$430

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 487 against 730. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 23.2 to 24.2 prescriptions per thousand people enrolled in North Dakota Medicaid, on an average of 101,142 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 29 of the 168 product-quarters it holds a row for here, which is 17 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by North Dakota Medicaid: no prescription was reported, and the reason is not published here.

Ozempic® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether North Dakota Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what North Dakota Medicaid paid for each product, quarter by quarter

Prescriptions North Dakota Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter¹No row
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁰Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁰Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁰Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁰Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable⁹Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁹Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable⁹Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable⁹Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable⁸Withheld6 of 6 product codes withheld	at least 12 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$12,672 paid	at least 27 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$28,573 paid	at least 28 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$29,636 paid	at least 44 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$47,641 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable¹⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable¹⁴Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable¹⁴Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable¹⁴Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable¹⁴Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable¹³Withheld2 of 2 product codes withheld
semaglutideOzempic®range 49 to 1,762, up 836 on the quarter before	at least 51 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$37,318 paid	83 paid prescriptions in the quarter (2021Q2)²⁴Count$66,355 paid	at least 69 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$56,608 paid	70 paid prescriptions in the quarter (2021Q4)²⁴Count$56,920 paid	66 paid prescriptions in the quarter (2022Q1)²³Count$55,939 paid	at least 58 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$48,500 paid	at least 54 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$44,145 paid	at least 55 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$46,745 paid	61 paid prescriptions in the quarter (2023Q1)²²Count$54,165 paid	at least 57 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$50,043 paid	49 paid prescriptions in the quarter (2023Q3)²²Count$40,937 paid	at least 32 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$26,735 paid	at least 40 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$34,189 paid	at least 42 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$36,377 paid	122 paid prescriptions in the quarter (2024Q3)²¹Count$112,942 paid	165 paid prescriptions in the quarter (2024Q4)²¹Count$156,324 paid	173 paid prescriptions in the quarter (2025Q1)²⁰Count$166,268 paid	241 paid prescriptions in the quarter (2025Q2)²⁰Count$231,770 paid	276 paid prescriptions in the quarter (2025Q3)²⁰Count$269,476 paid	926 paid prescriptions in the quarter (2025Q4)²⁰Count$899,747 paid	1,762 paid prescriptions in the quarter (2026Q1)¹⁹Count$1,752,427 paid
semaglutideRybelsus®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁰No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁰No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁰No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁰No row	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable²⁹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable²⁹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable²⁹Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter²⁹No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter²⁸No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter²⁸No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter²⁸No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable²⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable²⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable²⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable²⁷Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable²⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable²⁶Withheld3 of 3 product codes withheld	at least 11 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$10,763 paid	at least 30 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$30,166 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 126 to 1,490, up 202 on the quarter before	730 paid prescriptions in the quarter (2021Q1)⁴²Count$604,160 paid	874 paid prescriptions in the quarter (2021Q2)⁴²Count$729,563 paid	979 paid prescriptions in the quarter (2021Q3)⁴²Count$815,888 paid	993 paid prescriptions in the quarter (2021Q4)⁴²Count$840,785 paid	at least 1,084 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld⁴¹At least$952,888 paid	1,170 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,030,421 paid	at least 1,166 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld⁴¹At least$1,024,448 paid	1,291 paid prescriptions in the quarter (2022Q4)⁴¹Count$1,127,826 paid	1,373 paid prescriptions in the quarter (2023Q1)⁴⁰Count$1,253,014 paid	1,490 paid prescriptions in the quarter (2023Q2)⁴⁰Count$1,367,008 paid	at least 1,424 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$1,331,969 paid	1,433 paid prescriptions in the quarter (2023Q4)⁴⁰Count$1,337,259 paid	1,276 paid prescriptions in the quarter (2024Q1)³⁹Count$964,829 paid	at least 1,242 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$863,532 paid	at least 1,069 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$721,503 paid	1,233 paid prescriptions in the quarter (2024Q4)³⁹Count$852,440 paid	791 paid prescriptions in the quarter (2025Q1)³⁸Count$501,266 paid	141 paid prescriptions in the quarter (2025Q2)³⁸Count$92,384 paid	126 paid prescriptions in the quarter (2025Q3)³⁸Count$87,790 paid	285 paid prescriptions in the quarter (2025Q4)³⁸Count$201,317 paid	487 paid prescriptions in the quarter (2026Q1)³⁷Count$338,771 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 11 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$7,774 paid	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter⁴⁴No row	at least 985 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$368,035 paid	1,206 paid prescriptions in the quarter (2025Q3)⁴⁴Count$455,560 paid	at least 624 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$236,131 paid	at least 12 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$5,156 paid

What this page cannot tell you

Whether North Dakota Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open North Dakota in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, ND
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like ZEPBOUND%, state ND, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, ND
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like ZEPBOUND%, state ND, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, ND
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like ZEPBOUND%, state ND, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, ND
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND 5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, ND
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like ZEPBOUND%, state ND, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, ND
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like ZEPBOUND%, state ND, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, ND
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 7", "suppression_used": "false", "number_of_prescriptions": "18"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, ND
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, ND
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 1", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, ND
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 1", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, ND
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "MOUNJARO 2", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, ND
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like MOUNJARO%, state ND, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, ND
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, ND
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, ND
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, ND
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like WEGOVY%, state ND, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, ND
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like WEGOVY%, state ND, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, ND
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like WEGOVY%, state ND, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, ND
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "931"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, ND
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "551"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, ND
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, ND
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "31"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, ND
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2022", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "52"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, ND
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "48"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, ND
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, ND
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, ND
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, ND
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, ND
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, ND
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like RYBELSUS%, state ND, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, ND
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like SAXENDA%, state ND, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, ND
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like SAXENDA%, state ND, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, ND
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like SAXENDA%, state ND, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, ND
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like SAXENDA%, state ND, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, ND
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like SAXENDA%, state ND, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, ND
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like SAXENDA%, state ND, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, ND
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "303"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, ND
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "495"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, ND
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "833"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, ND
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "891"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, ND
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "750"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, ND
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "596"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, ND
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state ND, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ND", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, ND
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state ND, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "453"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, ND
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state ND, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, ND
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state ND, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like LIRAGLUTID%, state ND, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, ND
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state ND, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like LIRAGLUTID%, state ND, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, ND
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state ND, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ND", "product_name": "product_name like LIRAGLUTID%, state ND, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 19 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

How the quoted row is presented, for 29 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

Common questions

Does a paid prescription mean North Dakota Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.